Sectors
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
AbbVie has bought an exclusive option to acquire Mitokinin once the UCSF spinout completes IND-enabling studies for its Parkinson’s treatment.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Amadeus Capital Partners has bought a stake in the University of Oxford spinout through a secondary transaction, valuing it at around $2.4bn.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
Every day, Global University Venturing rounds up the smaller investments from across the university innovation ecosystem in its deal net.
GlaxoSmithKline is paying $176m for a 10% stake in University of Tübingen's RNA drug developer in connection with a strategic partnership agreement.
Global University Venturing (GUV) is where tech transfer, academic and investment experts meet to explore the latest ideas and technologies driving innovation forward. We drive the discussions and share best practices that are critical to the success of spinouts, scaleouts and innovation programmes. Our aim is to help improve the processes of bringing innovations from academia to global markets and facilitate their integration into the broader business ecosystem.
